McKesson Corporation Completes Divestiture of Canada-Based Rexall and Well.ca Businesses

IRVING, Texas — On December 30, 2024, McKesson Corporation announced that it has completed the sale of its Canada-based Rexall and Well.ca businesses. This strategic move comes after the initial announcement made in September 2024 regarding the transaction with Birch Hill Equity Partners, a well-known Canadian private equity firm.

This divestiture allows McKesson to redirect its resources and focus on expanding its key growth areas, particularly in oncology and biopharma. By concentrating on these strategic platforms, the company aims to enhance its capabilities in delivering healthcare services and products.

Rexall, a prominent pharmacy chain in Canada, along with Well.ca, an online health and wellness retailer, have been integral parts of McKesson’s operations in the country. However, the company is prioritizing investments that align more closely with its long-term business goals.

McKesson's decision reflects its commitment to enhancing health outcomes by focusing on aspects of the healthcare market that are increasingly critical. Following the transaction, McKesson intends to allocate its capital more efficiently and invest in areas that support its mission of making healthcare more accessible and affordable.

For investors and industry observers, more details about this divestiture and its implications for McKesson's future direction can be found on the company's Investor Relations webpage.

McKesson, divestiture, Canada